Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Tezepelumab-ekko
Medication labelTEZSPIRE is indicated for the add-on maintenance treatment of adult and pediatric patients aged 12 years and older with severe asthma.…
Why this: Advisory · dailymed-prescription
TEZSPIRE is indicated for the add-on maintenance treatment of adult and pediatric patients aged 12 years and older with severe asthma. Limitations of Use: TEZSPIRE is not indicated for the relief of acute bronchospasm or status asthmaticus.
- generic_name
- tezepelumab-ekko
- product_names
- tezepelumab-ekko
- ndc
- 55513-100, 55513-100-01, 55513-100-96, 55513-100-99, 55513-112, 55513-112-01, 55513-112-96, 55513-112-99, 55513-123, 55513-123-01, 55513-123-96
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en